Cellectar Biosciences (CLRB) Tops Q1 EPS by 30c
Tweet
Share
E-mailGet Alerts CLRB Hot Sheet
Join SI Premium – FREE
Cellectar Biosciences (NASDAQ: CLRB) reported Q1 EPS of $0.11, $0.30 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $89.3 million.
For earnings history and earnings-related data on Cellectar Biosciences (CLRB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple suing OpenAI over alleged misappropriation of trade secrets
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Holtec Nuclear Corporation files for initial public offering
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
